Product NDC: | 0527-1366 |
Proprietary Name: | Phentermine Resin |
Non Proprietary Name: | Phentermine Resin |
Active Ingredient(s): | 30 mg/1 & nbsp; Phentermine Resin |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0527-1366 |
Labeler Name: | Lannett Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040872 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110728 |
Package NDC: | 0527-1366-01 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0527-1366-01) |
NDC Code | 0527-1366-01 |
Proprietary Name | Phentermine Resin |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0527-1366-01) |
Product NDC | 0527-1366 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phentermine Resin |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110728 |
Marketing Category Name | ANDA |
Labeler Name | Lannett Company, Inc. |
Substance Name | PHENTERMINE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |